bone marrow involvement was demonstrated by immunohistological examination in 121/160 patients ( 76 % ) with non-hodgkin lymphomas ( nhl ) and 16/23 patients ( 70 % ) with plasma cell malignancies ;
C0024305
non-hodgkin lymphomas
C0032112
plasma cell